Literature DB >> 12942051

Transforming growth factor beta induced protein accumulation in granular corneal dystrophy type III (Reis-Bücklers dystrophy). Identification by mass spectrometry in 15 year old two-dimensional protein gels.

Chris J Hedegaard1, Ida B Thøgersen, Jan J Enghild, Gordon K Klintworth, Torben Møller-Pedersen.   

Abstract

PURPOSE: To investigate the accumulation of TGFBIp in GCDIII and to demonstrate the ability to perform mass spectrometry on old two-dimensional protein gels.
METHODS: Proteins were extracted from one cornea with GCDIII from a person with an Arg124Leu mutation in the TGFBI (BIGH3) gene and from one normal human cornea in 1987 and subjected to two-dimensional (2D) gel electrophoresis. After keeping the gels at room temperature for 15 years, protein spots of interest were excised and digested with trypsin. The tryptic-derived peptides were analyzed using mass spectrometry.
RESULTS: Four areas of interest were examined and four different proteins (TGFBIp, aldehyde dehydrogenase class 3, actin, and albumin) were identified in the 15-year-old gels. Using image analysis, the amount of TGFBIp was found to be 77 fold higher in the GCDIII affected cornea relative to the normal tissue. In both situations, TGFBIp migrated on the 2D gels as a 63 kDa protein. Mass spectrometry revealed the same nine peptides in TGFBIp from both the normal and the GCDIII affected corneas, including one peptide situated at the amino terminus. Moreover, the cornea with GCDIII contained abundant 40 kDa TGFBIp fragments that were lacking sequences in both the amino and carboxy termini.
CONCLUSIONS: Mass spectrometry can be performed on old 2D polyacrylamide gels. In both normal and GCDIII affected corneas, the majority of TGFBIp migrated on 2D gels as a 63 kDa protein with an intact amino terminus. However, the amount of the 63 kDa TGFBIp was 77 fold higher in the GCDIII affected cornea. Furthermore, the GCDIII affected cornea contained abundant 40 kDa fragments that were trunctated in both the amino and carboxy termini.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12942051

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  6 in total

1.  Fibril Core of Transforming Growth Factor Beta-Induced Protein (TGFBIp) Facilitates Aggregation of Corneal TGFBIp.

Authors:  Charlotte S Sørensen; Kasper Runager; Carsten Scavenius; Morten M Jensen; Nadia S Nielsen; Gunna Christiansen; Steen V Petersen; Henrik Karring; Kristian W Sanggaard; Jan J Enghild
Journal:  Biochemistry       Date:  2015-05-06       Impact factor: 3.162

2.  A novel variant of combined granular-lattice corneal dystrophy associated with the Met619Lys mutation in the TGFBI gene.

Authors:  Anthony J Aldave; Vivek S Yellore; Baris Sonmez; Nirit Bourla; Andrew K Salem; M Ali Khan; Sylvia A Rayner; Ben J Glasgow
Journal:  Arch Ophthalmol       Date:  2008-03

3.  Investigation of the influence of Arg555Trp and Thr538Pro TGFBI mutations on C-terminal cleavage and cell endoplasmic reticulum stress.

Authors:  Miaomiao Zhu; Ping Yu; Bo Jiang; Yangshun Gu
Journal:  Mol Vis       Date:  2012-05-03       Impact factor: 2.367

4.  Three kinds of corneal host cells contribute differently to corneal neovascularization.

Authors:  Haiyang Yu; Liyao Sun; Jing Cui; Yan Li; Yu Yan; Xi Wei; Chao Wang; Fanqian Song; Wentong Jiang; Yifan Liu; Hongyan Ge; Hua Qian; Xiaoguang Li; Xianling Tang; Ping Liu
Journal:  EBioMedicine       Date:  2019-05-22       Impact factor: 8.143

5.  Evidence against a blood derived origin for transforming growth factor beta induced protein in corneal disorders caused by mutations in the TGFBI gene.

Authors:  Henrik Karring; Zuzana Valnickova; Ida B Thøgersen; Chris J Hedegaard; Torben Møller-Pedersen; Torsten Kristensen; Gordon K Klintworth; Jan J Enghild
Journal:  Mol Vis       Date:  2007-06-27       Impact factor: 2.367

Review 6.  Transforming growth Factor-Beta-Induced Protein (TGFBI)/(βig-H3): a matrix protein with dual functions in ovarian cancer.

Authors:  Miranda P Ween; Martin K Oehler; Carmela Ricciardelli
Journal:  Int J Mol Sci       Date:  2012-08-21       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.